Meet Dr. Galan

Dr. Vincent Galan has practiced in the Atlanta area since 1988. In addition to being Director of its Anesthesia Department, he held the distinguished position of Director of Pain Center at Southern Regional Medical Center in Riverdale, Georgia from 1990 until 2008. In 2008 he founded his own practice, Pain Care, with the mission of providing every patient with exceptional service that includes a cost-effective, comprehensive, and ethical pain management program. Dr. Galan has the goal of exceeding the expectations of not only the injured patient, but also that of their referring physician.

On the cutting edge of Pain Management industry

Dr. Galan is actively involved in investigational pharmaceutical and device studies where he can not only offer his patients some of the latest medications before they get to the market, but also help advance our knowledge of the treatment of pain.

Dr. Galan is board certified in Anesthesia; triple boarded in Pain Medicine by the American Academy of Pain Medicine (AAPM), the American Board of Anesthesiology’s (ABA) Subspecialty Certification in Pain Management, and the American Board of Interventional Pain Physicians (ABIPP); he also has a fifth board certification in Addiction Medicine by the American Society of Addiction Medicine (ASAM).

Additionally, Dr. Galan has been contributed to the examination and test writing process for the three above mentioned national pain organizations. Dr. Galan completed his pain fellowship at Downstate Medical Center – SUNY. He then continued to Hermann Hospital, University of Texas, where he had the distinction to train as a visiting fellow with the well-renown Dr. P. P. Raj, Professor of Anesthesia at the University of Texas and Director of its Pain Clinic.

So what do all the letters behind his name mean?

Diplomate American Board of Anesthesia

Diplomate of American Board of Anesthesia, subspecialty Pain Medicine

Diplomate of American Board of Interventional Pain Physicians

PUBLICATIONS

Dr. Galan has published and presented many articles in regards to his research in various scholarly journals and meetings, including the following: The Journal of Palliative Medicine, The Journal of Pain, The Journal of Supportive Oncology and Pain Physician. Currently.

He has co-authored 3 articles in Pain Physician regarding guidelines and strategies to decrease opioid abuse:

Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. 2017; 20: S3-S92

Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: (Part 1). 2017; 20: S93-S109

Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2). 2017; 20: S111-E133

More recently:

Evaluating High Dose Parameters with Spinal Cord Stimulation in failed back surgery syndrome patients. Neuromodulation: Technology at the Neural Interface. 2018: 21(3):e1-e149.

Multicolumn Spinal Cord Stimulation for Predominant Back Pain in Failed Back Surgery Syndrome Patients: A Multicenter Randomized Controlled Trial. Pain. 2019;160(6):1410‐1420.

A Prospective Clinical Trial to Assess High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz in the Treatment of Chronic Intractable Pain from Peripheral Polyneuropathy (P2.6-065). Neurology Apr 2019, 92 (15 Supplement) P2.6-065.

Options: A Prospective, Open-Label Study of High-Dose Spinal Cord Stimulation in Patients with Chronic Back and Leg Pain. Pain Physician. 2020 Jan;23(1):87-98.

10 kHz SCS treatment for Painful Diabetic Neuropathy (PDN): Results from post hoc analysis of SENZA-PPN study. Pain Manag. 2020;10(5):291-300.

10 kHz spinal cord stimulation relieves pain in patients with painful diabetic neuropathy who are refractory to conventional treatments: Primary endpoint results from the SENZA-PDN RCT. Neurology 2020; 94 (15 S).

Long Term Efficacy of a Novel SCS Clinical Workflow Using Kilohertz Stimulation: 12-Month Results from the Vectors Study. Neuromodulation. 2021 Apr;24(3):556-565.

Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical Trial. JAMA Neurol. 2021 Jun 1;78(6):687-698.

Ten kHz spinal cord stimulation for the treatment of chronic peripheral polyneuropathy: 12-Month results from prospective open-label pilot study. Pain Practice. 2021;00:1–9.

Durability of high-frequency 10 kHz spinal cord stimulation for patients with painful diabetic neuropathy refractory to conventional treatments: 12-month results from a randomized controlled trial. Diabetes Care pending approval.

ADVISORY CONTRIBUTIONS

Other past and current membership positions I have served are: President and current Board member of the Georgia Society of Interventional Pain Physicians and Co-chair of our very successful annual meetings; American Society of Interventional Pain Physicians (ASIPP) Committee Guidelines; ASIPP Committee on Strategies for Future Alliances; ASIPP Committee on Development of State Societies; ASIPP 22nd Annual Meeting Organizing Committee; North American Neuromodulation Society (NANS) Advocacy and Policy Committee with participation in the DRG and SCS sub-committees; . American Society of Pain and Neuroscience (ASPN) Board Member, ASPN Leadership Council, ASPN Practice Management Committee, Medical Association of Georgia (MAG) Advisory Committee and the Georgia Attorney General Statewide Opioid Task Force.

He has presented abstracts or posters at the following congresses or annual meetings: Congress of the European Association for Palliative Care, American Pain Society, American Society of Pain Physicians Annual Meeting, North American Neuromodulation Society Annual Meetings and the International Neuromodulation Society World Congress.

Dr. Galan is a past contributor to the international journal “Pain Digest” and a past medical reviewer for the publishing company Williams and Wilkins. Currently, he serves in the Editorial Board as a Reviewer for Pain Medicine Case Reports - a Clinical Companion Journal to Pain Physician and he is in the North American Neuromodulation Society Abstract Review Committee.

He also served on the U.S. Advisory Board of Nasalfentanyl, a product for breakthrough Cancer Pain from Archimedes Pharmaceutical and the Advisory Board for Vertiflex (Totalis). Dr Galan has received Research Grants from Boston Scientific, St. Jude Medical, Nevro Corp., and Medtronic, for which he has been a consultant.

NEWNAN

2401 Newnan Crossing Blvd. East
Suite 120
Newnan, GA 30265

JOHNS CREEK

6300 Hospital Pkwy
Suite 265
Johns Creek, GA 30097